DCTHDelcath Systems, Inc.
Is the business good?
Margins widening. That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Operating margin has widened over the past few years, the business is getting more profitable per dollar of sales.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is DCTH?
Delcath Systems, Inc. keeps −1.9% of every revenue dollar as operating profit, against 0.61% for the median Medical Devices name.
Operating margin · Medical Devices median 0.61% · 12 months to Q2 2026
- Share count, year on year
- −1.3%
Share count, year on year · bought back, each share owns more of the company
- R&D as % of revenue
- 39%
R&D as % of revenue
- Gross margin
- 87%
Gross margin
| Year | Operating margin |
|---|---|
| FY2021 | −690% |
| FY2022 | −1245% |
| FY2023 | −1849% |
| FY2024 | −33% |
| FY2025 | 0.77% |
Details›
- Gross margin12 months to Q2 2026
- 87%
- Operating margin12 months to Q2 2026
- −1.9%
- Net margin12 months to Q2 2026
- 0.56%
- Free cash flow margin
- 18%
- R&D as % of revenue
- 39%
- Revenue, trailing twelve months
- $95M
- Free cash flow, trailing twelve months
- $18M
- Net income, trailing twelve months
- $532K
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Customers and suppliers
Who buys from DCTH and who it buys from, as the companies report it.
- Customer 115%
Share of revenue · FY2025 10-K
None disclosed.
A company has to disclose every customer behind 10% or more of its revenue. Each share comes from the latest annual report of the company that states it and shows on both companies’ pages; DCTH’s own figures are from its FY2025 10-K. Smaller customers and suppliers go unreported.